Why Abbott Laboratories Shot Higher Today

Abbott Laboratories (NYSE: ABT) easily surmounted Hump Day, rising by 3.4% and trouncing the S&P 500 index's gain as it did so. The reason was the company's impressive third quarter, the results of which were published that morning.

For the quarter, Abbott posted year-over-year sales growth of 23%, as its top line landed at $10.9 billion. Non-GAAP (adjusted) net income ballooned even more, expanding by 43% to just over $2.5 billion ($1.40 per share).

Image source: Getty Images.

Continue reading

Source Fool.com